Momenta Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/20 Q2

ended 03/31/20 Q1

ended 12/31/19 FY 2019

ended 09/30/19 Q3

ended 06/30/19 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Stoner Elizabeth

Gutierrez-Ramos Jose-Carlos

Grogan Donna Roy

Gilman Steven C

News Filter

Announces Completion of Proposed Sale to Johnson & Johnson

Enters Definitive Agreement With Johnson & Johnson

Reports Second Quarter 2020 Financial and Operating Results

Change in Directors, Officers or Compensation, Shareholder Vote Results

Announces Positive Topline Data From Interim Analysis of Phase 2 Vivacity-Mg Study of Nipocalimab (M281) in Generalized Myasthenia Gravis

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order